Candel Therapeutics annual debt-to-assets ratio
2020
2021
2022
2023
2024
2025
Candel Therapeutics Debt-to-Assets Ratio Growth & History (CADL)
Candel Therapeutics's debt-to-assets ratio was 0.02 for fiscal 2025.
View full Candel Therapeutics company overviewCandel Therapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.02 | −0.10 | −87.10% |
| 2024 | 2024-12-31 | 0.12 | −0.42 | −77.93% |
| 2023 | 2023-12-31 | 0.53 | 0.51 | +2028.47% |
| 2022 | 2022-12-31 | 0.03 | 0.02 | +299.82% |
| 2021 | 2021-12-31 | 0.01 | −0.01 | −50.24% |
| 2020 | 2020-12-31 | 0.01 | — | — |
Candel Therapeutics quarterly debt-to-assets ratio
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.01 | −0.06 | −88.40% |
| Q1 2026 | 2026-03-31 | 0.01 | −0.10 | −91.48% |
| Q4 2025 | 2025-12-31 | 0.02 | −0.10 | −87.10% |
| Q3 2025 | 2025-09-30 | 0.07 | −0.64 | −90.56% |
| Q2 2025 | 2025-06-30 | 0.07 | −0.60 | −89.58% |
| Q1 2025 | 2025-03-31 | 0.10 | −0.55 | −83.95% |
| Q4 2024 | 2024-12-31 | 0.12 | −0.42 | −77.93% |
| Q3 2024 | 2024-09-30 | 0.71 | 0.27 | +60.23% |
| Q2 2024 | 2024-06-30 | 0.67 | 0.29 | +78.21% |
| Q1 2024 | 2024-03-31 | 0.65 | 0.32 | +97.75% |
| Q4 2023 | 2023-12-31 | 0.53 | 0.51 | +2028.47% |
| Q3 2023 | 2023-09-30 | 0.44 | 0.42 | +1717.26% |
| Q2 2023 | 2023-06-30 | 0.38 | 0.35 | +1520.80% |
| Q1 2023 | 2023-03-31 | 0.33 | 0.31 | +1373.51% |
| Q4 2022 | 2022-12-31 | 0.03 | 0.02 | +299.82% |
| Q3 2022 | 2022-09-30 | 0.02 | 0.02 | +329.84% |
| Q2 2022 | 2022-06-30 | 0.02 | 0.01 | +36.93% |
| Q1 2022 | 2022-03-31 | 0.02 | — | — |
| Q4 2021 | 2021-12-31 | 0.01 | −0.01 | −50.24% |
| Q3 2021 | 2021-09-30 | 0.01 | — | — |
| Q2 2021 | 2021-06-30 | 0.02 | — | — |
| Q4 2020 | 2020-12-31 | 0.01 | — | — |
Candel Therapeutics debt-to-assets ratio trends
Over the last five fiscal years, Candel Therapeutics's debt-to-assets ratio increased from 0.01 to 0.02, a change of 0.00. The latest reported quarter, Q2 2026, shows 0.01.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Candel Therapeutics source filings ↗